세계의 정형외과 플래닝 시스템 시장 : 제품 유형별, 최종 사용자별, 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카)-산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has conducted a thorough analysis of the Orthopedic Planning Systems Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Orthopedic Planning Systems Market spanning from 2024 to 2031.

In 2024, global revenue from orthopedic planning systems reached US$ 86.15 million, projected to grow at a CAGR of 7.9%, reaching US$ 158.2 million by 2031.

Key Insights:

• Orthopedic Planning Systems Market Size (2024): US$ 86.15 Mn
• Projected Market Value (2031): US$ 158.2 Mn
• Global Market Growth Rate (2024-2031): 7.9% CAGR

Orthopedic Planning Systems Market - Report Scope

The global orthopedic planning systems market offers various solutions for orthopedic surgeons and healthcare providers, facilitating surgical planning and implant selection. Key drivers include advancements in medical technology, increasing prevalence of orthopedic disorders, and the growing aging population. Emerging trends focus on personalized medicine and 3D printing applications. Overall, the market is driven by the rising demand for efficient surgical procedures, improved patient outcomes, and the need for cost-effective healthcare solutions.

Market Growth Drivers

The expanding adoption of orthopedic planning systems is fueled by several interconnected factors, including technological innovation and the growing acceptance of minimally invasive surgical techniques. Advances in imaging modalities and computer-assisted surgery enhance surgical accuracy and patient safety, driving the demand for orthopedic planning solutions. Additionally, demographic shifts, such as an aging population and rising obesity rates, contribute to the increasing incidence of orthopedic conditions, boosting market growth. As healthcare providers strive to optimize treatment outcomes and minimize complications, orthopedic planning systems play a crucial role in streamlining surgical procedures and enhancing patient care.

Market Restraints

Challenges facing the orthopedic planning systems market include regulatory hurdles, reimbursement limitations, and data security concerns. Compliance with stringent regulatory requirements for medical devices and software poses challenges for market players, necessitating substantial investments in research and development and regulatory compliance efforts. Moreover, reimbursement policies vary across regions, impacting the adoption of orthopedic planning systems and healthcare provider decisions. Data security and patient privacy concerns also present barriers to market growth, requiring robust cybersecurity measures and compliance with data protection regulations to safeguard patient information.

Opportunities

Opportunities for market growth in the orthopedic planning systems segment include expanding applications in emerging markets, technological advancements, and strategic partnerships. The rising prevalence of orthopedic disorders in developing countries creates opportunities for market expansion, as healthcare infrastructure improves and access to advanced medical technologies increases. Furthermore, ongoing innovations in 3D printing and artificial intelligence offer opportunities to enhance the capabilities of orthopedic planning systems, enabling personalized treatment approaches and optimizing surgical outcomes. Collaborations between orthopedic device manufacturers, software developers, and healthcare institutions facilitate the development of integrated solutions that address the evolving needs of orthopedic surgeons and patients.

Key Questions Answered in Report::

• What are the key drivers propelling the growth of the orthopedic planning systems market?
• What emerging trends are shaping the landscape of orthopedic planning systems?
• What are the primary challenges hindering market expansion, and how can they be mitigated?
• What opportunities exist for market players to capitalize on in the orthopedic planning systems segment?

Competitive Intelligence and Business Strategy

In October 2020, EOS imaging installed its first EOSedge(TM) system at the Macquarie University Hospital in Australia, marking a significant milestone for the company in expanding its market presence.

In December 2020, Zimmer Biomet bolstered its product offerings by acquiring A&E Medical, gaining access to a diverse portfolio of sternal closure devices, including cable systems and sternal sutures.

In April 2020, Brainlab achieved CE Mark approval for its advanced patient positioning and monitoring system, ExacTrac(R) Dynamic, demonstrating its commitment to innovation and meeting regulatory standards.

Key Companies Profiled

• Formus Labs Ltd,
• EOS imaging,
• Brainlab AG,
• Sectra AB,
• Stryker,
• Materialise,
• Medstrat,
• mediCAD Hectec GmbH,
• 3D Systems, Inc.,
• PEEK HEALTH S.A,
• Radlink, Inc.,
• SurgiNovi,
• RSA Biomedical,
• HIPOP-PLAN,
• Zimmer Biomet,
• Optinav,
• Enhatch Inc.,

Key Segments Covered in Orthopedic Planning Systems Industry Research

Orthopedic Planning Systems Market by Solution:

• Pre-Surgical Planning Software

o2D Planning Software

o3D Planning Software

• Post-Surgical Planning Software

Orthopedic Planning Systems Market by Application:

• Joint Replacement

oHip Replacement

oKnee Replacement

oShoulder Replacement

oSmall Bone Replacement

• Orthopaedic Oncology

Orthopedic Planning Systems Market by Deployment:

• Web Based Software
• Cloud Based Software
• On Premises

Orthopedic Planning Systems Market by End User:

• Hospitals
• Ambulatory Surgical Centers
• Orthopaedic Office-Based Clinics

Orthopedic Planning Systems Market by Region:

• North America Orthopedic Planning Systems Market
• Latin America Orthopedic Planning Systems Market
• Europe Orthopedic Planning Systems Market
• South Asia Orthopedic Planning Systems Market
• East Asia Orthopedic Planning Systems Market
• Oceania Orthopedic Planning Systems Market
• Middle East & Africa Orthopedic Planning Systems Market

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Market Background

• 4.1. Macro-Economic factors
  • 4.1.1. Global Healthcare Market Outlook
  • 4.1.2. Healthcare IT Spending Outlook, By U.S. & Global
  • 4.1.3. U.S. per-Capita Healthcare Expenditure
• 4.2. Forecast Factors
  • 4.2.1. Evaluation of Incremental Costs and Effectiveness
  • 4.2.2. Increasing Spending on Healthcare Per Capita
  • 4.2.3. Increasing Spending for Healthcare Infrastructure Development Post COVID-19 Pandemic
  • 4.2.4. Application of biomedical and nanotechnology in Orthopaedics
• 4.3. Market Dynamics
  • 4.3.1. Demand
  • 4.3.2. Restraints
  • 4.3.3. Opportunity
• 4.4. Global Supply Demand Analysis

5. COVID19 Crisis Analysis

• 5.1. Current COVID19 Statistics and Probable Future Impact
• 5.2. COVID19 and Impact Analysis
  • 5.2.1. By Solution
  • 5.2.2. By Application
  • 5.2.3. By Deployment
  • 5.2.4. By End User

6. Key Success Factors

• 6.1. Key Developments
• 6.2. Regulatory Scenario
• 6.3. Key Deals and Contracts
• 6.4. Number of Surgeries, By Region

7. Global Orthopedic Planning Systems Market - Pricing Analysis

• 7.1. Country-wise & Regional Pricing Analysis, By Solution
• 7.2. Pricing Break-up
  • 7.2.1. Manufacturer Level Pricing
  • 7.2.2. Distributor Level Pricing
• 7.3. Global Average Pricing Analysis Benchmark

8. Global Orthopedic Planning Systems Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

• 8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 8.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
  • 8.2.1. Y-o-Y Growth Trend Analysis
  • 8.2.2. Absolute $ Opportunity Analysis

9. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Solution

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis, By Solution, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Solution, 2024-2031
  • 9.3.1. Orthopedic Planning Systems
    • 9.3.1.1. Pre-Surgical Planning Software
      • 9.3.1.1.1. 2D Planning Software
      • 9.3.1.1.2. 3D Planning Software
    • 9.3.1.2. Post-Surgical Planning Software
• 9.4. Market Attractiveness Analysis, By Solution

10. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Application

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 10.3.1. Orthopedic Surgery
    • 10.3.1.1. Joint Replacement
      • 10.3.1.1.1. Hip Replacement
      • 10.3.1.1.2. Knee Replacement
      • 10.3.1.1.3. Shoulder Replacement
      • 10.3.1.1.4. Small Bone Replacement
  • 10.3.2. Orthopedic Oncology
• 10.4. Market Attractiveness Analysis, By Application

11. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Deployment

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis, By Deployment, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Deployment, 2024-2031
  • 11.3.1. Web Based Software
  • 11.3.2. Cloud Based Software
  • 11.3.3. On Premises
• 11.4. Market Attractiveness Analysis, By Deployment

12. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
  • 12.3.1. Hospitals
  • 12.3.2. Ambulatory Surgical Centres
  • 12.3.3. Orthopedic Office-Based
  • 12.3.4. Clinics
• 12.4. Market Attractiveness Analysis, By End User

13. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
• 13.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (MEA)
• 13.4. Market Attractiveness Analysis, By Region

14. North America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 14.1. Introduction
• 14.2. Pricing Analysis
• 14.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 14.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 14.4.1. By Country
    • 14.4.1.1. U.S.
    • 14.4.1.2. Canada
  • 14.4.2. By Solution
  • 14.4.3. By Application
  • 14.4.4. By Deployment
  • 14.4.5. By End User
• 14.5. Market Attractiveness Analysis
  • 14.5.1. By Country
  • 14.5.2. By Solution
  • 14.5.3. By Application
  • 14.5.4. By Deployment
  • 14.5.5. By End User
• 14.6. Market Trends
• 14.7. Key Market Participants - Intensity Mapping
• 14.8. Drivers and Restraints - Impact Analysis

15. Latin America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 15.1. Introduction
• 15.2. Pricing Analysis
• 15.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 15.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 15.4.1. By Country
    • 15.4.1.1. Brazil
    • 15.4.1.2. Mexico
    • 15.4.1.3. Rest of Latin America
  • 15.4.2. By Solution
  • 15.4.3. By Application
  • 15.4.4. By Deployment
  • 15.4.5. By End User
• 15.5. Market Attractiveness Analysis
  • 15.5.1. By Country
  • 15.5.2. By Solution
  • 15.5.3. By Application
  • 15.5.4. By Deployment
  • 15.5.5. By End User
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis

16. Europe Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 16.1. Introduction
• 16.2. Pricing Analysis
• 16.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 16.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 16.4.1. By Country
    • 16.4.1.1. Germany
    • 16.4.1.2. Italy
    • 16.4.1.3. France
    • 16.4.1.4. U.K.
    • 16.4.1.5. Spain
    • 16.4.1.6. BENELUX
    • 16.4.1.7. Russia
    • 16.4.1.8. Rest of Europe
  • 16.4.2. By Solution
  • 16.4.3. By Application
  • 16.4.4. By Deployment
  • 16.4.5. By End User
• 16.5. Market Attractiveness Analysis
  • 16.5.1. By Country
  • 16.5.2. By Solution
  • 16.5.3. By Application
  • 16.5.4. By Deployment
  • 16.5.5. By End User
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis

17. South Asia and Pacific Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 17.1. Introduction
• 17.2. Pricing Analysis
• 17.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 17.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 17.4.1. By Country
    • 17.4.1.1. India
    • 17.4.1.2. ASEAN
    • 17.4.1.3. Oceania
    • 17.4.1.4. Rest of South Asia & Pacific
  • 17.4.2. By Solution
  • 17.4.3. By Application
  • 17.4.4. By Deployment
  • 17.4.5. By End User
• 17.5. Market Attractiveness Analysis
  • 17.5.1. By Country
  • 17.5.2. By Solution
  • 17.5.3. By Application
  • 17.5.4. By Deployment
  • 17.5.5. By End User
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis

18. East Asia Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 18.1. Introduction
• 18.2. Pricing Analysis
• 18.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 18.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 18.4.1. By Country
    • 18.4.1.1. China
    • 18.4.1.2. Japan
    • 18.4.1.3. South Korea
  • 18.4.2. By Solution
  • 18.4.3. By Application
  • 18.4.4. By Deployment
  • 18.4.5. By End User
• 18.5. Market Attractiveness Analysis
  • 18.5.1. By Country
  • 18.5.2. By Solution
  • 18.5.3. By Application
  • 18.5.4. By Deployment
  • 18.5.5. By End User
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis

19. Oceania Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 19.1. Introduction
• 19.2. Pricing Analysis
• 19.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 19.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 19.4.1. By Country
    • 19.4.1.1. Australia
    • 19.4.1.2. New Zealand
  • 19.4.2. By Solution
  • 19.4.3. By Application
  • 19.4.4. By Deployment
  • 19.4.5. By End User
• 19.5. Market Attractiveness Analysis
  • 19.5.1. By Country
  • 19.5.2. By Solution
  • 19.5.3. By Application
  • 19.5.4. By Deployment
  • 19.5.5. By End User
• 19.6. Market Trends
• 19.7. Key Market Participants - Intensity Mapping
• 19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 20.1. Introduction
• 20.2. Pricing Analysis
• 20.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 20.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 20.4.1. By Country
    • 20.4.1.1. GCC Countries
    • 20.4.1.2. Turkey
    • 20.4.1.3. Northern Africa
    • 20.4.1.4. South Africa
    • 20.4.1.5. Rest of Middle East and Africa
  • 20.4.2. By Solution
  • 20.4.3. By Application
  • 20.4.4. By Deployment
  • 20.4.5. By End User
• 20.5. Market Attractiveness Analysis
  • 20.5.1. By Country
  • 20.5.2. By Solution
  • 20.5.3. By Application
  • 20.5.4. By Deployment
  • 20.5.5. By End User
• 20.6. Market Trends
• 20.7. Key Market Participants - Intensity Mapping
• 20.8. Drivers and Restraints - Impact Analysis

21. Country Level Orthopedic Planning Systems Market Analysis 2024-2031

• 21.1. Introduction
  • 21.1.1. Market Value Proportion Analysis
  • 21.1.2. Global VS. Country Growth Comparison
  • 21.1.3. Pricing Analysis, by Country
• 21.2. U.S. Orthopedic Planning Systems Market Analysis
  • 21.2.1. By Solution
  • 21.2.2. By Application
  • 21.2.3. By Deployment
  • 21.2.4. By End User
• 21.3. Canada Orthopedic Planning Systems Market Analysis
  • 21.3.1. By Solution
  • 21.3.2. By Application
  • 21.3.3. By Deployment
  • 21.3.4. By End User
• 21.4. Mexico Orthopedic Planning Systems Market Analysis
  • 21.4.1. By Solution
  • 21.4.2. By Application
  • 21.4.3. By Deployment
  • 21.4.4. By End User
• 21.5. Brazil Orthopedic Planning Systems Market Analysis
  • 21.5.1. By Solution
  • 21.5.2. By Application
  • 21.5.3. By Deployment
  • 21.5.4. By End User
• 21.6. Germany Orthopedic Planning Systems Market Analysis
  • 21.6.1. By Solution
  • 21.6.2. By Application
  • 21.6.3. By Deployment
  • 21.6.4. By End User
• 21.7. Italy Orthopedic Planning Systems Market Analysis
  • 21.7.1. By Solution
  • 21.7.2. By Application
  • 21.7.3. By Deployment
  • 21.7.4. By End User
• 21.8. France Orthopedic Planning Systems Market Analysis
  • 21.8.1. By Solution
  • 21.8.2. By Application
  • 21.8.3. By Deployment
  • 21.8.4. By End User
• 21.9. U.K. Orthopedic Planning Systems Market Analysis
  • 21.9.1. By Solution
  • 21.9.2. By Application
  • 21.9.3. By Deployment
  • 21.9.4. By End User
• 21.10. Spain Orthopedic Planning Systems Market Analysis
  • 21.10.1. By Solution
  • 21.10.2. By Application
  • 21.10.3. By Deployment
  • 21.10.4. By End User
• 21.11. Russia Orthopedic Planning Systems Market Analysis
  • 21.11.1. By Solution
  • 21.11.2. By Application
  • 21.11.3. By Deployment
  • 21.11.4. By End User
• 21.12. China Orthopedic Planning Systems Market Analysis
  • 21.12.1. By Solution
  • 21.12.2. By Application
  • 21.12.3. By Deployment
  • 21.12.4. By End User
• 21.13. Japan Orthopedic Planning Systems Market Analysis
  • 21.13.1. By Solution
  • 21.13.2. By Application
  • 21.13.3. By Deployment
  • 21.13.4. By End User
• 21.14. S. Korea Orthopedic Planning Systems Market Analysis
  • 21.14.1. By Solution
  • 21.14.2. By Application
  • 21.14.3. By Deployment
  • 21.14.4. By End User
• 21.15. India Orthopedic Planning Systems Market Analysis
  • 21.15.1. By Solution
  • 21.15.2. By Application
  • 21.15.3. By Deployment
  • 21.15.4. By End User
• 21.16. ASEAN Orthopedic Planning Systems Market Analysis
  • 21.16.1. By Solution
  • 21.16.2. By Application
  • 21.16.3. By Deployment
  • 21.16.4. By End User
• 21.17. Australia Orthopedic Planning Systems Market Analysis
  • 21.17.1. By Solution
  • 21.17.2. By Application
  • 21.17.3. By Deployment
  • 21.17.4. By End User
• 21.18. New Zealand Orthopedic Planning Systems Market Analysis
  • 21.18.1. By Solution
  • 21.18.2. By Application
  • 21.18.3. By Deployment
  • 21.18.4. By End User
• 21.19. Turkey Orthopedic Planning Systems Market Analysis
  • 21.19.1. By Solution
  • 21.19.2. By Application
  • 21.19.3. By Deployment
  • 21.19.4. By End User
• 21.20. South Africa Orthopedic Planning Systems Market Analysis
  • 21.20.1. By Solution
  • 21.20.2. By Application
  • 21.20.3. By Deployment
  • 21.20.4. By End User

22. Market Structure Analysis

• 22.1. Market Analysis, By Tier of Companies (Orthopedic Planning Systems)
• 22.2. Market Share Analysis of Top Players
• 22.3. Market Presence Analysis
  • 22.3.1. By Regional footprint of Players
  • 22.3.2. Device foot print by Players
  • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

• 23.1. Competition Dashboard
• 23.2. Competition Benchmarking
• 23.3. Competition Deep Dive
  • 23.3.1. Formus Labs Ltd
    • 23.3.1.1. Overview & Key financials
    • 23.3.1.2. Product Portfolio
    • 23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.1.4. SWOT Analysis
    • 23.3.1.5. Sales Footprint
    • 23.3.1.6. Strategy Overview
    • 23.3.1.7. Sales and Marketing strategies
    • 23.3.1.8. Channel Strategies
  • 23.3.2. EOS imaging
    • 23.3.2.1. Overview & Key financials
    • 23.3.2.2. Product Portfolio
    • 23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.2.4. SWOT Analysis
    • 23.3.2.5. Sales Footprint
    • 23.3.2.6. Strategy Overview
    • 23.3.2.7. Sales and Marketing strategies
    • 23.3.2.8. Channel Strategies
  • 23.3.3. Brainlab AG
    • 23.3.3.1. Overview & Key financials
    • 23.3.3.2. Product Portfolio
    • 23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.3.4. SWOT Analysis
    • 23.3.3.5. Sales Footprint
    • 23.3.3.6. Strategy Overview
    • 23.3.3.7. Sales and Marketing strategies
    • 23.3.3.8. Channel Strategies
  • 23.3.4. Sectra AB
    • 23.3.4.1. Overview & Key financials
    • 23.3.4.2. Product Portfolio
    • 23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.4.4. SWOT Analysis
    • 23.3.4.5. Sales Footprint
    • 23.3.4.6. Strategy Overview
    • 23.3.4.7. Sales and Marketing strategies
    • 23.3.4.8. Channel Strategies
  • 23.3.5. Stryker
    • 23.3.5.1. Overview & Key financials
    • 23.3.5.2. Product Portfolio
    • 23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.5.4. SWOT Analysis
    • 23.3.5.5. Sales Footprint
    • 23.3.5.6. Strategy Overview
    • 23.3.5.7. Sales and Marketing strategies
    • 23.3.5.8. Channel Strategies
  • 23.3.6. Materialise
    • 23.3.6.1. Overview & Key financials
    • 23.3.6.2. Product Portfolio
    • 23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.6.4. SWOT Analysis
    • 23.3.6.5. Sales Footprint
    • 23.3.6.6. Strategy Overview
    • 23.3.6.7. Sales and Marketing strategies
    • 23.3.6.8. Channel Strategies
  • 23.3.7. Medstrat
    • 23.3.7.1. Overview & Key financials
    • 23.3.7.2. Product Portfolio
    • 23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.7.4. SWOT Analysis
    • 23.3.7.5. Sales Footprint
    • 23.3.7.6. Strategy Overview
    • 23.3.7.7. Sales and Marketing strategies
    • 23.3.7.8. Channel Strategies
  • 23.3.8. MediCAD Hectec GmbH
    • 23.3.8.1. Overview & Key financials
    • 23.3.8.2. Product Portfolio
    • 23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.8.4. SWOT Analysis
    • 23.3.8.5. Sales Footprint
    • 23.3.8.6. Strategy Overview
    • 23.3.8.7. Sales and Marketing strategies
    • 23.3.8.8. Channel Strategies
  • 23.3.9. 3D Systems, Inc
    • 23.3.9.1. Overview & Key financials
    • 23.3.9.2. Product Portfolio
    • 23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.9.4. SWOT Analysis
    • 23.3.9.5. Sales Footprint
    • 23.3.9.6. Strategy Overview
    • 23.3.9.7. Sales and Marketing strategies
    • 23.3.9.8. Channel Strategies
  • 23.3.10. PEEK HEALTH S.A
    • 23.3.10.1. Overview & Key financials
    • 23.3.10.2. Product Portfolio
    • 23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.10.4. SWOT Analysis
    • 23.3.10.5. Sales Footprint
    • 23.3.10.6. Strategy Overview
    • 23.3.10.7. Sales and Marketing strategies
    • 23.3.10.8. Channel Strategies
  • 23.3.11. Radlink, Inc.
    • 23.3.11.1. Overview & Key financials
    • 23.3.11.2. Product Portfolio
    • 23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.11.4. SWOT Analysis
    • 23.3.11.5. Sales Footprint
    • 23.3.11.6. Strategy Overview
    • 23.3.11.7. Sales and Marketing strategies
    • 23.3.11.8. Channel Strategies
  • 23.3.12. SurgiNovi
    • 23.3.12.1. Overview & Key financials
    • 23.3.12.2. Product Portfolio
    • 23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.12.4. SWOT Analysis
    • 23.3.12.5. Sales Footprint
    • 23.3.12.6. Strategy Overview
    • 23.3.12.7. Sales and Marketing strategies
    • 23.3.12.8. Channel Strategies
  • 23.3.13. RSA Biomedical
    • 23.3.13.1. Overview & Key financials
    • 23.3.13.2. Product Portfolio
    • 23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.13.4. SWOT Analysis
    • 23.3.13.5. Sales Footprint
    • 23.3.13.6. Strategy Overview
    • 23.3.13.7. Sales and Marketing strategies
    • 23.3.13.8. Channel Strategies
  • 23.3.14. HIPOP-PLAN
    • 23.3.14.1. Overview & Key financials
    • 23.3.14.2. Product Portfolio
    • 23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.14.4. SWOT Analysis
    • 23.3.14.5. Sales Footprint
    • 23.3.14.6. Strategy Overview
    • 23.3.14.7. Sales and Marketing strategies
    • 23.3.14.8. Channel Strategies
  • 23.3.15. Zimmer Biomet.
    • 23.3.15.1. Overview & Key financials
    • 23.3.15.2. Product Portfolio
    • 23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.15.4. SWOT Analysis
    • 23.3.15.5. Sales Footprint
    • 23.3.15.6. Strategy Overview
    • 23.3.15.7. Sales and Marketing strategies
    • 23.3.15.8. Channel Strategies
  • 23.3.16. Optinav
    • 23.3.16.1. Overview & Key financials
    • 23.3.16.2. Product Portfolio
    • 23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.16.4. SWOT Analysis
    • 23.3.16.5. Sales Footprint
    • 23.3.16.6. Strategy Overview
    • 23.3.16.7. Sales and Marketing strategies
    • 23.3.16.8. Channel Strategies
  • 23.3.17. Enhatch Inc.
    • 23.3.17.1. Overview & Key financials
    • 23.3.17.2. Product Portfolio
    • 23.3.17.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.17.4. SWOT Analysis
    • 23.3.17.5. Sales Footprint
    • 23.3.17.6. Strategy Overview
    • 23.3.17.7. Sales and Marketing strategies
    • 23.3.17.8. Channel Strategies
  • 23.3.18. Numex GmbH
    • 23.3.18.1. Overview & Key financials
    • 23.3.18.2. Product Portfolio
    • 23.3.18.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.18.4. SWOT Analysis
    • 23.3.18.5. Sales Footprint
    • 23.3.18.6. Strategy Overview
    • 23.3.18.7. Sales and Marketing strategies
    • 23.3.18.8. Channel Strategies
  • 23.3.19. Corin Group
    • 23.3.19.1. Overview & Key financials
    • 23.3.19.2. Product Portfolio
    • 23.3.19.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.19.4. SWOT Analysis
    • 23.3.19.5. Sales Footprint
    • 23.3.19.6. Strategy Overview
    • 23.3.19.7. Sales and Marketing strategies
    • 23.3.19.8. Channel Strategies

24. Assumptions and Acronyms Used

25. Research Methodology